Depression :: Looking for better ways to treat depression
Researchers have deciphered how neurotransmitter transporter proteins recognise their targets, a finding which may provide clues for better design of drugs used to treat depression.
Researchers have deciphered how neurotransmitter transporter proteins recognise their targets, a finding which may provide clues for better design of drugs used to treat depression.
Around ?2-million is to be spent to help reduce the number of people dying from drug overdoses or contracting blood-borne viruses through injecting themselves with dirty needles.
The British Association of Aesthetic Plastic Surgeons, the not-for-profit organisation established for the advancement of education and practice of Aesthetic Plastic Surgery for public benefit, denounced new courses set up to train GPs in the latest aesthetic treatments.
The General Medical Council (GMC) has launched a consultation to find out how doctors and patients can best work together to make decisions about treatment.
A UK primary care trust made a public apology to the family of a patient who died from multiple organ failure due to severe flaws in the care provided by an out-of-hours GP service.
AIDS Healthcare Foundation (AHF), the largest AIDS healthcare, prevention and education provider in the United States and operator of free AIDS treatment clinics in the US, Africa, Latin America/Caribbean and Asia unveiled a public awareness campaign targeting negative direct-to-consumer advertising of HIV/AIDS drugs by pharmaceutical companies.
WHO published World health statistics 2007, the most complete set of health statistics from its 193 Member States. This edition also highlights trends in 10 of the most closely watched global health statistics.
Follow-up of breast cancer patients after their initial treatment is becoming “devalued and deregulated”, according to new research published online in the cancer journal, Annals of Oncology.
Early-stage research has found that a new gene therapy can nearly eliminate arthritis pain, and significantly reduce long-term damage to the affected joints, according to a study published in the journal Arthritis and Rheumatism.
The Endocrine Society urges physicians to respond in a measured way to a recent study suggesting the diabetes drug Avandia (rosiglitazone) increases the risk of heart disease and heart attacks.